DD209621A5 - Verfahren zur herstellung von enantiomeren substituierter phenylazacycloalkane - Google Patents

Verfahren zur herstellung von enantiomeren substituierter phenylazacycloalkane Download PDF

Info

Publication number
DD209621A5
DD209621A5 DD83249351A DD24935183A DD209621A5 DD 209621 A5 DD209621 A5 DD 209621A5 DD 83249351 A DD83249351 A DD 83249351A DD 24935183 A DD24935183 A DD 24935183A DD 209621 A5 DD209621 A5 DD 209621A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
group
carbon atoms
formula
radical
Prior art date
Application number
DD83249351A
Other languages
German (de)
English (en)
Inventor
Folke L Arvidsson
Per A E Carlsson
Uli A Hacksell
Anette M Johansson
Per L Lindberg
John L G Nilsson
Domingo Sanchez
Kjell A I Svensson
Hakan V Wikstroem
John St M Hjorth
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of DD209621A5 publication Critical patent/DD209621A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DD83249351A 1982-03-30 1983-03-30 Verfahren zur herstellung von enantiomeren substituierter phenylazacycloalkane DD209621A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8202023A SE446335B (sv) 1982-03-30 1982-03-30 Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin

Publications (1)

Publication Number Publication Date
DD209621A5 true DD209621A5 (de) 1984-05-16

Family

ID=20346417

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83249351A DD209621A5 (de) 1982-03-30 1983-03-30 Verfahren zur herstellung von enantiomeren substituierter phenylazacycloalkane

Country Status (17)

Country Link
EP (1) EP0097628B1 (fr)
JP (1) JPS58177971A (fr)
AT (1) ATE56705T1 (fr)
AU (1) AU564287B2 (fr)
CA (1) CA1202307A (fr)
DD (1) DD209621A5 (fr)
DE (1) DE3381885D1 (fr)
DK (1) DK162214C (fr)
ES (3) ES8405372A1 (fr)
FI (1) FI81088C (fr)
GB (1) GB2117771B (fr)
GR (1) GR79244B (fr)
HU (1) HU191290B (fr)
IE (1) IE55261B1 (fr)
NO (1) NO164024C (fr)
PT (1) PT76481B (fr)
SE (1) SE446335B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8305362D0 (sv) * 1983-09-30 1983-09-30 Astra Laekemedel Ab Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
JP2011057619A (ja) * 2009-09-10 2011-03-24 Tokai Univ 光学活性アミン化合物の製造方法、並びに、ジアステレオマー塩及びその製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030526B1 (fr) * 1979-12-05 1985-02-27 Astra Läkemedel Aktiebolag Phényl-azacycloalcanes, procédés de préparation et préparations pharmaceutiques contenant ces composés

Also Published As

Publication number Publication date
AU1284583A (en) 1983-10-06
GB2117771A (en) 1983-10-19
ES8601889A1 (es) 1985-11-16
PT76481B (en) 1986-02-27
SE8202023L (sv) 1983-10-01
FI81088B (fi) 1990-05-31
PT76481A (en) 1983-04-01
ES521080A0 (es) 1984-06-01
GB2117771B (en) 1985-12-04
FI81088C (fi) 1990-09-10
ES8405372A1 (es) 1984-06-01
IE55261B1 (en) 1990-07-18
DK143483A (da) 1983-10-01
ATE56705T1 (de) 1990-10-15
DK143483D0 (da) 1983-03-29
ES539031A0 (es) 1985-11-16
GR79244B (fr) 1984-10-22
GB8308657D0 (en) 1983-05-05
NO164024C (no) 1990-08-22
DK162214C (da) 1992-03-16
EP0097628A2 (fr) 1984-01-04
IE830685L (en) 1983-09-30
JPS6155906B2 (fr) 1986-11-29
SE446335B (sv) 1986-09-01
ES530186A0 (es) 1985-12-01
EP0097628A3 (en) 1984-07-18
DE3381885D1 (de) 1990-10-25
AU564287B2 (en) 1987-08-06
NO164024B (no) 1990-05-14
FI831068A0 (fi) 1983-03-29
ES8602655A1 (es) 1985-12-01
CA1202307A (fr) 1986-03-25
DK162214B (da) 1991-09-30
JPS58177971A (ja) 1983-10-18
EP0097628B1 (fr) 1990-09-19
FI831068L (fi) 1983-10-01
NO831040L (no) 1983-10-03
HU191290B (en) 1987-02-27

Similar Documents

Publication Publication Date Title
DE60209929T2 (de) Succinatsalze von 58;8;14-triatetracyclo[10.3.1.0 2,11 .0 4,9]-hexadeca-2,11,3,5,7,9,-pentaen und pharmazeutische zusammensetzungen
DE9290063U1 (de) Chinuclidin-Derivate
DE2437610A1 (de) Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
DE2411382A1 (de) Neue 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
DE69220133T2 (de) N-Cyclohexyl Benzamide Derivate, ihre Herstellungen und therapeutischen Anwendungen
DD216716A5 (de) Verfahren zur herstellung von octahydrobenzo (f)chinolinen
DE2305092C2 (fr)
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
EP0149840B1 (fr) Dihydro-5,11 6h-dibenzo[b,e]azépinones-6 substituées, procédé pour leur préparation et médicaments contenant ces composés
DE2108954A1 (en) 2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
DE3586411T2 (de) Dopamin-antagoniste.
DD155065A5 (de) Verfahren zur herstellung von phenylazacycloalkanen
CH626343A5 (fr)
DE69002474T2 (de) Carboxyalkyl-ether von 2-Amino-7-hydroxytetralin.
DE10048715A1 (de) Verwendung von Aminosäure zur Behandlung von Schmerz
EP0064685A1 (fr) Dibenzo(de,g)quinolines, leurs procédés de préparation et les médicaments les contenant
DD209621A5 (de) Verfahren zur herstellung von enantiomeren substituierter phenylazacycloalkane
EP0389425B1 (fr) Benzothiopyranylamines
DE2834107A1 (de) Benzylalkoholderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2207430C3 (de) 1,2,4,5-Tetrahydro-3H-3-benzazepin, ein Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel
DE2657950A1 (de) Trifluormethylthioderivate von cyproheptadin
DE68905799T2 (de) (+)1-[(3,4,5-Trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
DE1931487C3 (de) In 5-Stellung substituierte 5,10-Dihydro-11H-dibenzo eckige Klammer auf b,e eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu diazepin-11 -one und Verfahren zu ihrer Herstellung
EP0086980B1 (fr) Dibenzodiazépinones substituées, procédé pour leur fabrication et médicaments contenant ces composés

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee